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Leishmania donovani, the causative organism of visceral leishmaniasis (VL) is one of the deadliest
of the entire known Leishmania species. This protozoan parasite displays immense adaptability to
survive under extremely harsh conditions. Cell surface glycoconjugates play a pivotal role in parasite
virulence and infectivity. This review mainly highlights on the importance of these molecules and
their reported roles with special emphasis on L. donovani sialobiology. The recently evolved
information reported by our group regarding the identification and characterization of sialoglycans
and their possible mode(s) of acquisition as also the detailed identification, characterization of
anti-O-acetylated sialic acid (anti-OAcSA) antibodies and their emerging biological roles, notably
as molecules that may aid in host defense against the pathogen has been vividly discussed in this
review.
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Leishmaniasis is endemic in about 88 countries and
is responsible for the annual loss of 2.4 million disability
adjusted life-years and over 59,000 deaths1. The visceral
form of the disease is mainly caused by Leishmania
donovani, L. chagasi, or L. infantum, and 500,000 new
cases of visceral leishmaniasis (VL) occur each year2.
Approximately 50 per cent of the world’s cases of VL
occur in the Indian subcontinent, and about 90 per cent
of Indian patients with VL live in Bihar3.
Considering the wide global distribution and
consequent burden of leishmaniasis, research efforts
are presently being directed towards discovering
novel molecular determinants on the parasite surface.
These molecules may help us in gaining an insight
into their role in host pathogen interaction as also
whether such interactions could be exploited to target
parasite death.
Leishmania parasites while shuttling between
intermediate carriers and vertebrate hosts encounter
extremely harsh conditions and their survival
strategies are designed to keep invaders at bay.
Their survival strategies frequently involve the
participation of glycoconjugates that form a
protective barrier against hostile environment. In fact,
a common feature of parasite cell surface architecture
is the presence of an elaborate and highly decorative
glycocalyx that allows the parasite to interact with
and respond to its external environment. Cell
membrane bound carbohydrates and sugars play a
key role in parasite survival and proliferation. Most
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of these specialized molecules are members of a
family of phosphoglycans while others are a family
of glycoinositol phosholipids4.
Glycoconjugates of Leishmania donovani
Throughout their life cycle, Leishmania survive
and proliferate in highly hostile environments and
have evolved special mechanisms that enable them
to endure these adverse conditions. To protect
themselves from such harsh conditions one of
the adaptive mechanisms includes the production
of a dense cell surface glycocalyx composed of
lipophosphoglycan (LPG), glycosylinositol
phospholipids, or GIPLs5,6 and secreted
glycoconjugates, proteophosphoglycan (PPG)7-9, and
secreted acid phosphatase (sAP)10-12.
Lipophosphoglycan (LPG)
The cell surface of leishmania promastigotes
predominantly comprises of LPGs. It is localized
over the entire parasite surface, including the
flagellum. Found in all species of Leishmania that
infect humans, it is composed of four domains, (i) a
1-O-alkyl-2-lyso-phosphatidyl(myo)inositol lipid
anchor, (ii) a glycan core, (iii) Gal(b1,4) Man (a1)-
PO4 backbone repeat units, and ( iv) an
oligosaccharide cap structure13,14. Structural analysis
of LPG from different species has revealed complete
conservation of the lipid anchor, the glycan core, and
the Gal (β1, 4) Man (α1)-PO4 backbone of repeat
units. The distinguishing features of LPG are in the
variations in the carbohydrate chains that branch off
the main backbone and in the cap structures15. The
C3 hydroxyl of the repeat unit Gal is the site of most
side chain modifications. The LPG of L. donovani
from Sudan does not possess any side chains, whereas
the L. donovani LPG from India possesses one to two
β-Glc every four to five repeat units16. The most
common L.  donovani  cap is the branched
trisaccharide Gal (β1,4) [Man (α1,2)] Man (α1).
LPG serves as the ligand for binding to lectins in
the sandfly midgut, and thus structural variations
correlate with infectivity and transmission by various
sandfly species. Structural modifications are
observed as the parasite progresses through various
life stages. L. donovani attaches to its natural sandfly
vector’s midgut via the LPG cap structure, which
terminates in a b-linked Gal and a-linked Man.
Although both are required for binding, there is no
information on the putative receptor or lectin. As the
procyclic promastigotes undergo metacyclogenesis,
the number of repeat units doubles from
approximately 15 to 3017. This is believed to result
in a conformational change that masks the terminal
cap sequence and thus allows the parasite to detach
from the midgut and migrate anteriorly.
The number of LPG molecules expressed by
the intracellular  amastigotes is substantially
downregulated. A number of functions have been
implicated for LPG in the mammalian host. In the
blood stream, LPG prevents complement-mediated
lysis by preventing insertion of the C5b-9 membrane
attack complex into the promastigote membrane. It
serves as a ligand for receptor-mediated endocytosis
by the macrophage via complement receptors as well
as the mannose receptor. Inside the macrophage LPG
inhibits  protein kinase C and the microbicidal
oxidative burst as well as phagosome-endosome
fusion14 (Table I).
GIPLs
The GIPLs are a major family of low molecular
weight glycolipids  synthesized by Leishmania
parasites, which are not attached to either proteins
or polysaccharides18-20,4. These are expressed in
very high copy numbers, approximately 107 copies
per cell on both promastigote and amastigote
surfaces. There are three major lineages of GIPLs
that are expressed to different levels in different
species or developmental stages.  Based on the
pattern of their glycan head groups they are
classified as type I (analogous to protein GPI
anchors and based on the structure Manα1,6
Manα1,4GlcNα1,6-PI), type II (analogous to LPG
anchors  and based on the s tructure
Manα1,3Manα1,4GlcNα1,6-PI) ,  or  hybrid
(contains features of both and based on the
Manα1,6(Manα1,3)Manα1,4GlcNα1,6-PI motif).
The lipid components of the hybrid and type I
GIPLs are rich in alkyl-acyl-PI with shorter
(C18:0) alkyl chains. The type II GIPLs are more
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heterogeneous and contain longer alkyl chains
(C24:0 or C26:0).
Not much is known about the functions of the
GIPLs. The use of the mannose receptor in parasite
attachment to the macrophage suggests that the
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mannose-rich GIPLs may play a role in macrophage
invasion. Because the levels of LPG and the major
promastigote surface protease, gp63, are dramatically
downregulated, the GIPLs are the major constituents
of the amastigote surface and are presumably
involved in protecting the parasite from
Table I. Major glycoconjugates of Leishmania donovani: occurrence and possible biological roles
Glycoconjugates Promastigote Amastigote References
LPG
(Structure composed of Number of LPG molecules bear Number of LPG down-regulated. 13, 14, 17
phosphatidyl(myo)inositol lipid direct correlation with infectivity, LPG of amastigotes inhibits
anchor, glycan core, during metacyclogenesis the protein kinase C and the
Gal(β1,4)Man(α1)-PO4 carbohydrate repeat units doubles microbicidal oxidative burst as
backbone repeat units from approx 15 to 30. LPG prevents well as phagosome-endosome
oligosaccharide cap structure) complement-mediated lysis of the fusion
promastigote and serves as a ligand
for receptor-mediated endocytosis by
the macrophage
GIPLs Present. Major constituents of the 4, 18, 19,
(Protein free glycolipids) Have a role in macrophage invasion amastigote surface. 20, 21, 22,
Involved in modulating signaling 23, 24, 25
events in the macrophage such as
NO synthesis and the oxidative burst.
gp63 Major cell surface glycoprotein found Expressed in lower level found in 26, 27, 28,
(Glycoprotein, zinc on entire surface. Serves as a ligand for the flagellar pocket 29
metalloprotease) the macrophage receptor via complement
components protect against complement
mediated lysis.Proteolytically cleaves
host macromolecules
sAP (glycosylated proteins) Secreted from the flagella Not reported 7, 8, 10, 30,
31, 32
PPG GPI-anchored cell associated Secrete their own non filamentous 8, 9, 11, 32,
(Proteophosphoglycans) filamentous form termed mPPG The form termed aPPG.aPPG is believed 33, 34, 35,
gel-like matrix, formed by these to contribute to the formation of the 36
interlocking filaments, traps the parasitophorous vacuole, thus
parasites in the sandfly anterior gut participating in the maintenance of
infection.Activate the complement
system via the mannose-binding
pathway
Phosphoglycan Present function not yet defined. Not reported 13
(hydrophilic phosphoglycan
consisting of capped
oligosaccharide repeat units
but minus the GPI anchor and
the glycan core
Sialoglycans Sialic acid derivatives present, but Sialic acid derivatives present. 37, 38, 68
(sialic acid derivatives) Neu 5Gc absent the O acetylated forms Neu5Gc present. Role not yet
activate the classical complement known.
pathway.
LPG, lipophosphoglycans; GIPLs, glycosylinositol phospholipids; gp63, glycoprotein63; sAP, secreted acid phosphatase;
GPI,glycosylphosphatidylinositol
environmental hazards as well as playing some role
in parasite-host interactions, especially in the
mammalian stage. In fact, there is evidence that
GIPLs are involved in modulating signaling events
in the macrophage such as NO synthesis and the
oxidative burst21-24. There are recent data to show that
enzymes involved in glycosylphosphatidylinositols
(GPI) biosynthesis are essential for parasite
virulence25, thus emphasizing the importance of
protein-free GPI glycolipids in parasite viability.
gp63
gp63 is the major cell surface glycoprotein of
Leishmania promastigotes with 500,000 copies per cell
and accounting for 1 per cent of all cellular proteins.
In amastigotes gp63 is expressed to a lower level, and
the bulk of it is found in the flagellar pocket as opposed
to covering the entire surface, as in promastigotes26.
It is a 63-kDa zinc metalloprotease and is anchored to
the cell surface via a myristic acid containing gpI
anchor. The amastigote gp63 subpopulation found in
the flagellar pocket lacks a membrane anchor. The
crystal structure has been solved and found to contain
an active site structural motif found in other zinc
proteases that may aid design of specific inhibitors27.
Primary sequence analysis has shown that gp63
contains three potential glycosylation sites28. The
glycans are biantennary high mannose-type, and some
bear a terminal Glc in α1,3 linkage. The two major
structures found in all promastigote species examined
are Man6GlcNAc2 and GlcMan6GlcNAc2. In
amastigotes the structures are more variable, and in
L. donovani there appear to be no N-linked glycans.
The presence of terminal Glc in the gp63 glycan is
highly unusual with respect to oligomannose structures
found in glycoproteins. Whether the stage-specific
changes in glycan structure affect parasite infectivity
and development is unknown.
The importance of gp63 in parasite life cycle is
not well defined.  gp63 has been shown to be
proteolytically active against a number of substrates
and thus may be involved in degradation of host
macromolecules. It may also serve as a ligand for
the macrophage receptor via complement components
and protect the parasite against complement mediated
lysis29.
Secreted glycoconjugates
In addition to cell surface LPG and GIPLs,
Leishmania secrete a family of heavily glycosylated
proteins and proteoglycans that are important for
parasite virulence. Most of these express glycans that
are similar in structure to those found on LPG, notably
the Gal-Man-PO4 repeat unit motif. The structural
features of secreted acid phosphatase, phosphoglycan
and proteophosphoglycan are briefly outlined below30.
sAP: With the exception of L. major, all Leishmania
promastigotes secrete sAP from the flagellar pocket,
their chief  secretory organelle10,31,32. The secreted
glycoproteins and proteoglycans tend to form distinct
macromolecular complexes found both in the
flagellar pocket as well as the culture media. Old
World species, such as L. donovani, L. tropica, and
L. aethiopica secrete mono- or oligomeric sAPs,
whereas the South American species, such as
L. mexicana, L. braziliensis, and L. amazonensis
secrete sAPs that aggregate into large pearl-like
filamentous polymers7,8,30. The sAPs are encoded by
multiple genes that have very high levels of sequence
identity, even within different species. The
L. donovani sAP peptides are heavily glycosylated
on C-terminal serine/threonine-rich domains. The
glycans are phosphodiester-linked to serine residues
and commonly consist of the 6Gal(β1,4)Man
(α1-)PO4 repeat units found on LPG. The average
number of repeat units is 32. The target sites of
phosphoglycosylation are not random, rather, they are
composed of repetitive motifs, with modifications
on select serine residues.
PPG
Proteophosphoglycans (PPG) identified to date in
promastigotes include filamentous PPG or fPPG and
a putative GPI-anchored cell-associated form or
mPPG8,11,32.  Amastigotes secrete their own
nonfilamentous and stage-specific form termed
aPPG33. The filamentous form, fPPG, is secreted by
promastigotes of all Leishmania species and forms a
highly viscous mesh within which the parasites lie
embedded. Compositionally fPPG consists of 95 per
cent phosphoglycans, with an abundance of serine,
alanine, and proline in the peptide component. Over
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80-90 per cent of the serine  residues are
phosphoglycosylated with short Gal-Man-PO4
repeats attached via phosphodiester bonds, which are
terminated by small oligosaccharide cap structures9.
Although there is no direct evidence for the function
of fPPG, it is believed that the gel-like matrix, formed
by the interlocking filaments, traps the parasites in
the sandfly anterior gut.  Further, it has been
hypothesized that the presence of the parasite plug
deters the ingestion of a second blood meal, thereby
encouraging the sandfly to probe several hosts and
in the process improve the chances of transmission34.
Within the macrophage, aPPG is believed to
contribute to the formation of the parasitophorous
vacuole, thus participating in the maintenance of
infection in the mammalian host35,36. Amastigote PPG
is believed to activate the complement system via the
mannose-binding pathway by virtue of the large
number of potential mannose-binding lectin-binding
sites. There is also evidence that PPG may contribute
to the binding of Leishmania to host cells and may
play a role in modulating the biology of the infected
macrophage at the early stage of infection.
Phosphoglycan
Culture supernatants of Leishmania promastigotes
contain a hydrophilic phosphoglycan consisting of
capped oligosaccharide repeat units identical to those
found on LPG, but minus the GPI anchor and the
glycan core13. The structure precludes the possibility
of phosphatidylinositol-specific phospholipase C (PI-
PLC)-mediated release from LPG, rather it is thought
to have been released from the flagellar pocket via
exocytosis.
Sialoglycans on L. donovani
The topography of Leishmania parasites with
regard to their sialoglycan profile remains a poorly
investigated area and it is only recently that the status
of sialoglycans on L. donovani promastigotes as well
as amastigotes has been reported from our
laboratory37,38.
Sialic acids typically present as terminal residues
on glycoproteins and glycolipids are known to play
a significant role in the mediation of many biological
phenomena involving cell-cell and cell-matrix
interactions by either reacting with specific surface
receptors or masking other carbohydrate recognition
sites39,40.
Sialic acids are a structurally complex family of
nine-carbon polyhydroxy amino ketoacid of N- and
O-substituted derivatives of neuraminic acid, a
monosaccharide commonly referred to as N-
acetylneuraminic acid or Neu5Ac41. It is the most
abundantly available monosaccharide present as the
terminal residue of cell surface sugar chains. Its
strategic terminal position provides it accessibility,
reflected in its regulation of a multitude of cellular
and molecular interactions39. Over 50 different
modifications of sialic acid are generated following
substitution of the amino group by an acetyl or
glycolyl group and one or more hydroxyl groups by
methylation or esterification with acetyl, lactyl,
sulphate or phosphate groups40.
However, the most frequently occurring
modification (over 18) is O-acetylation at position
C-7/8/9 to form N-acetyl-7/8/9-O-acetylneuraminic
acid respectively generating a family of O-acetylated
sialoglycoconjugates or O-AcSGs41.
To address the status of sialoglycans on the
protozoa, several analytical, biochemical and
Immunological methods were performed in our
laboratory. Interestingly, The chromatogram of the
parasite promastigote exhibited well-resolved peaks
that coincided with that of sialic acid and one, co-
migrating with 9-Oacetylated sialic acid, which
resembles 7.7 per cent of total sialic acids. The cells
contained about 800 ng of sialic acid in 2 x 109 cells
corresponding to 7 x 105 molecules of sialic acid per
cell (Table II). The total amount of sialic acids and
derivative quantified on the amastigotes was 658 ng/
1.6x109 cells of which the majority is only sialic acid
corresponding to 385ng. The number of copies of
sialic acid residues per cell was thus found to be
12.8 x 105. This data were further confirmed with
mass spectrometry analysis of trimethylester
derivatives of the parasite promastigote sample, sialic
acid was clearly detected in the parasite as evident
from the mass fragmentography of sialic acid having
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fragment ions (m/z) at 668, 624, 478, 400, 317, and
298, respectively37. Mass spectrometric analysis also
confirmed the presence of sialic acids on amastigotes
by mass fragmentography, principally being sialic
acid and Neu5Gc showing fragment ions (m/z).
Although the presence of Neu5Ac and Neu5Gc
was detectable on L. donovani amastigotes both by
HPLC and mass spectroscopy, Neu5Gc was not
observed on promastigotes by similar analysis37.
Although Neu5Gc is a major sialic acid derivative
in most mammals (including our closest evolutionary
relatives, the great apes42), it is thought to be absent
in healthy humans43. Considering the wide
differences in Neu5Gc expression in certain parasitic
diseases44, it is important to check the status of this
sugar and its functional relevance in L. donovani;
such studies are ongoing. HPLC analysis also
demonstrated that amastigotes have a 2.0 fold higher
copy number of Neu5Ac than promastigotes38
(Fig. 1).
The surface density of sialoglycoconjugates present
on L. donovani promastigotes was examined further
by flow cytometric analysis using two sialic acid-
binding plant lectins, Sambucus nigra agglutinin
(SNA) and Maackia amurensis agglutinin (MAA), that
recognize α2-6 and α2-3 sialylgalactosyl residues,
respectively45,46. Low binding with MAA and high
amounts of SNA binding indicated the predominance
of α2-6 linked sialylglycotopes on the parasite
promastigote. Corroborative evidence for the presence
of α2-3 and α2-6 linked sialoglycans on the
L. donovani promastigotes was provided further by
the binding of various recombinant sialic acid binding
lectins (Siglecs). Siglecs, members of the
immunoglobulin superfamily, bind to sialic acids and
are mainly expressed by cells of the haematopoietic
system47. Although the binding pattern appeared
complex, most Siglecs tested showed some degree of
binding (Table III). Siglecs exhibit widely differing
preferences for sialic acid linkage to subterminal
sugars. For example, CD22/Siglec-2 binds only to
α2-6-linked sialic acids, whereas sialoadhesin/Siglec-
1 prefers α2-3-linked sialic acids and Siglec-5 binds
both linkages. The presence of α2-6 linked sialic acids
on the parasite cell surface was consistent with their
Table II. Quantitative analysis of sialic acids on Leishmania
donovani by high pressure liquid chromatography (HPLC)
analysis
Derivative Promastigotes* Amastigotes**
ng/2x109 cells ng/1.6x109 cells
Number of sialic
acid molecules/
cells 7x105 12.8x105
Neu5Gc Could not be 175
detected
Neu5Ac 800 385
Neu5Gc9Ac Could not be 12
detected
Neu5Ac9Ac 7.7 per cent of total 4
sialic acid
*Adapted from Chatterjee et al, Glycobiology, 2003 (Ref. 37)
**Adapted from Chava et al, J Biol Chem, 2004 (Ref. 38)
Fig. 1. Fluorimetric high performance liquid chromatography
(HPLC) analysis of sialic acid (Neu5Ac) and its derivatives on
Leishmania donovani promastigotes and amastigotes.
[Reproduced from (Ref. 37 & 38) with permission of the
publishers, Oxford University Press and Walter de Gruyter
GmbH & Co press].
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binding to Siglec-2/CD22, known to require sialic
acids α2 α6 linked to Galb1 a 4GlcNAc sequences
for recognition48. Further, the lower binding with
Siglec-1 and Siglec-8 that prefer α2-3-linked sialic
acids points toward the predominance of α2-6 linked
sialic acids.  Taken together, these results support the
idea that sialic acids, both α2-3 and α2-6 linked, are
present on Leishmania promastigotes.
A similar pattern of binding was also observed
with Leishmania amastigotes. In general, the binding
of siglecs was 2-3 fold higher in amastigotes than
promastigotes. More importantly, siglec 1 which is
abundantly present on macrophages showed an
almost three-fold higher binding with amastigotes
than promastigotes. It remains to be investigated
whether these sialoglycans are playing a major role
in the infectivity and intracellular survival of the
parasite.
Molecular characterization of sialoglycans
present on the promastigote parasite surface, was
examined by their reactivity towards two plant
lectins, SNA and MAA by western blotting. Using
SNA, the presence of three sialoglycoproteins
corresponding to 123, 90, and 70 kDa were
identified on parasite membranes. As compared to
90 and 70 kDa, the expression of 123 kDa was much
weaker. In case of MAA, five sialoglycans were
identified that corresponded to 130, 117, 106, 70,
and 61 kDa37 (Fig. 2A).
Western blotting of amastigote membrane
glycoproteins with SNA demonstrated the presence
of two sialoglycoconjugates 164 kDa and 150 kDa.
Similarly, binding of MAA demonstrated the
presence of five distinct sialoglycans corresponding
to molecular masses of 188, 162, 136, 137 and 124
kDa. Interestingly, the sialoglycans adsorbed from
serum onto promastigotes are different from those
present on amastigotes. This raises the possibility that
during transformation to the amastigote form,
parasites acquire a new array of sialoglycans onto
their surface (Fig. 2B).
Futher, to examine the possible presence of
O-Acetylated derivative of sialic acid on the cell
surface of L. donovani promastigotes and amastigotes
Achatinin-H, a snail lectin with defined specificity
towards 9-O-AcSA, was used as a probe. The
selective binding of Achatinin-H with promastigotes
was observed through agglutination, enzyme linked
immunosorbant assay as also by flow cytometric
analysis (Fig. 3). The presence of 9-O-acetylated
determinants on L. donovani promastigotes was also
confirmed using the CD60b-specific monoclonal
antibody UM4D4, whose epitope has been, defined
as 9-O-acetylated ganglioside GD3 and related
structures49.
To further characterize the O-acetylated
sialoglycoproteins present on L. donovani
promastigote membranes, western blotting was
Table III. Lectin binding patterns of Leishmania donovani
Probe Linkage specificity Occurrence Binding (%)
Promastigotes Amastigotes
SNA α 2-6 Sambucus nigra agglutinin 72.0 ± 14.3 87.7 ± 6.5
(SNA)
MAA α 2-3 Maackia amurensis 41.0 ± 6.3 27.24 ± 3.4
agglutinin (MAA)
Achatinin-H 9-OAcSA α 2-6 GalNAc Achatina fulica snail 44.3 ± 3.4 49.3 ± 4.5
Siglec-1 α 2-3 > α 2-6 Macrophage 17.3 ± 3.7 48.0 ± 2.7
Siglec-2 α 2-6 >> α 2-3 B cell 50.5 ± 11.4 54.0  ± 3.5
Siglec-5 α 2-3 = α 2-6 Neutrophils, myeloid cells 31.4 ± 3.7 60.0 ± 2.6
Siglec-7 α 2-6 > α 2-3 NKcells, monocytes 19.0 ± 4.3 61.0 ± 3.1
Siglec-8 α 2-3 Eosinophils 28.65 ± 4.2 65.0 ± 3.7
Siglec-10 α 2-3 = α 2-6 Myeloid cells 32.5 ± 1.5 40.0 ± 2.2
Mean ± SD of positive cells as determined by flow activated cell sorter (FACS) analysis using sialic acid binding probes
Adapted from Chava et al, J Biol Chem, 2004 (Ref. 38)
NK, natural killer
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performed. Achatinin-H bound to two O-acetylated
sialoglycoproteins corresponding to 123 and 109
kDa. Similarly, two O-acetylated sialoglycoproteins
corresponding to 164 and 150 kDa could be detected
on the amastigote cell surface upon blotting with
Achatinin-H37,38 (Fig. 2A, B).
Biosynthetic pathways of glycoconjugates
Leishmania synthesize a range of mannose-rich
glycoconjugates that form the cell  surface
glycocalyx or are secreted. These glycoconjugates
comprise GPI-anchored glycoproteins, the GPI-
anchored lipophosphoglycan, the
glycoinositolphospholipids (GIPLs) and the PPGs
described above. Biosynthesis of all  these
macromolecules depends directly or indirectly on
the availability of GDP-mannose. As mentioned
Fig. 2. Flow cytometric analysis of cell surface sialoglycans on
Leishmania donovani promastigotes (A) using Achatinin-H
before (light gray dashed line) and after esterase treatment (bold
line) as compared to control (solid thin blak line) and
amastigotes (B) control vs using Achatinin-H before and after
esterase treatment.
[Reproduced from (Ref. 37 & 38) with permission of the
publishers, Oxford University Press and Walter de Gruyter
GmbH & Co press].
Fig. 3. Western blot analysis of sialoglycoproteins present
on Leishmania donovani (A) Molecular characterization of
sialoglycoproteins present on L. donovani promastigotes were
electrophoresed (7.5% SDS PAGE) and following transfer
onto nitrocellulose membranes were incubated with SNA
(lane 1) or MAA (lane 3) or Achatinin-H (lane 5). Similarly
Western blot was carried out to demonstrate the binding of
SNA (lane 2), MAA (lane 4) and Achatinin-H (lane 6) to
medium M199 containing 10 per cent fetal calf serum. (B)
Amastigote membrane was electrophoresed (10%SDS PAGE)
and transferred onto nitrocellulose. The membranes were
incubated with MAA (lane 1) or SNA (lane 2) or Achatinin-
H (lane 3). [Reproduced from (Ref. 37 & 38) with permission
of the publishers, Oxford University Press and Walter de
Gruyter GmbH & Co press].
above, several of these molecules are considered
virulence factors, and parasites lacking them cannot
survive in macrophages or mice.
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A prerequisite for the biosynthesis of
glycoconjugates in Leishmania,  like in other
eukaryotes, is the conversion of monosaccharides to
activated sugar nucleotides and dolicholphosphate
derivatives. The activation of mannose involves
phosphomannomutase (PMM), GDP-Man
pyrophosphorylase (GDP-MP) and
dolicholphosphate-Man synthase (DPMS). GDP-MP
is a critical enzyme in the mannose biosynthetic
pathway. The consecutive action of PMM and GDP-
MP transforms Man-6-PO4 to GDP-Man which is
essential for glycoconjugate synthesis in eukaryotes.
The gene encoding GDP-MP is a single copy gene
expressed in both parasite life cycle stages. Deletion
of the GDP-MP leads to the loss of virulence as
reflected by survival in macrophages or mice.
The first distinct step in GPI biosynthesis is the
generation of N-acetylglucosaminyl-
phosphatidylinositol (GlcNAc-PI) from UDP-
GlcNAc and specific PI substrate (different PI pools
are used for GPI anchor, LPG and GIPLs pathway in
the parasite) catalyzed by the GPI-N-GlcNAc-
transferase (GPI-GnT), the GlcNAc-PI is then N-
deacylated to form glucosaminyl
phosphatidylinositol (GlcN-PI). This has been
proposed that the synthesis of GlcN-PI occurs on the
cytoplasmic side of endoplasmic reticulum (ER) and
then these intermediate GlcN-PI and/or GlcN-acyl-
PI translocate to the luminal side (mediated by a
putative “flippase”) where first three mannosyl
residues are transferred from Dol-P-Man50.
The most striking feature of LPG structure is the
variable phosphoglycan (PG) domain composed of
[6-Gal (β1, 4) Man (1α-PO4) repeats linked together
by phosphodiester groups. The PG repeats are
signature motif of phosphoglycan family of
molecules expressed both in the promastigote (lipid
linked phosphoglycan such as LPG) and amastigote
(protein linked phosphoglycan PPG) phase of the
parasite. The biosynthesis of PG repeats occurs inside
the golgi (after the pre-assembled GPI core is
translocated from ER to golgi) and involve a set of
putative initiating and elongating Man-1α-PO4-
transferases (iMPT and eMPT respectively). These
MPTs are unique to Leishmania parasite and are
capable of transferring intact Man-a-phosphate (and
not just the Man) from the GDP-Man nucleotide
sugar donor. Interestingly a unique GDP-Man
transporter (GMP antiporter) has recently been
identified in Leishmania  golgi vesicles51. The
biosynthetic assembly and trafficking of PG repeats
and involvement of unique MPTs and GDP-Man-
transporter are interesting target for synthesis,
conformation and inhibitor design51,52.
Detection of these sialic acids raises the obvious
question regarding the mechanism(s) adopted by the
parasite to acquire these terminal sugar molecules.
No biosynthetic machinery for sialic acid has been
elucidated in Trypanosoma parasites possessing sialic
acids on their cell surface53. Barring a few bacteria,
biosynthesis of sialic acids is restricted to
multicellular organisms, the key enzyme being UDP-
GlcNAc 2-epimerase, which catalyzes the first step
of this pathway and shows a strong feedback
inhibition54. Therefore, it follows that, if L. donovani
should have its own sialic acid biosynthesis,
expression of UDP-GlcNAc 2-epimerase activity
would be necessary. The accumulated data from our
laboratory clearly showed that L. donovani has no
UDP-GlcNAc 2-epimerase activity and consequently
does not possess a machinery for sialic acid
biosynthesis37. Trypanosomal parasites possess trans-
sialidases, which enable them to transfer
glycosidically linked sialic acids from the
environment (e.g., serum sialoglycoconjugates onto
parasite surface molecules)55. However, among
Leishmania species, the presence of such trans-
sialidases has not been demonstrated56. The presence
of serum trans-sialidases is still a matter of debate,
and it would be interesting to analyze whether such
trans-sialidases are operative in leishmaniasis,
accounting for parasite sialylation. Alternatively,
another approach that the parasite might well utilize
is ecto-sialyl transferases or serum sialyl transferases
that would catalyze the transfer of sialic acid from
the nucleotide sugar donor CMP-sialic acid onto
acceptor glycoconjugates57. However, such
enzymatic reactions would require the presence of
CMP-sialic acid, whose presence in serum of VL
patients is yet to be substantiated. Another option
that the parasite may adopt is to acquire sialic acid
from the growth medium either by transglycosylation
or by incorporation of serum components to the
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parasite polyanionic lipophosphoglycan, LPG/
proteophosphoglycan- rich cell surface58,59. However,
this maybe ruled out because the Western blotting
showed discrete glycoprotein bands and not a smear
(10 to 60 kDa) characteristic of lipophosphoglycan60.
Parasitologists are limited by lack of availability of
genomic data on protozoa, and therefore the search
for genes possibly involved in the biosynthesis,
activation or transfer of sialic acids in protozoa still
remains unanswered40. Our studies indicate that there
is a direct transfer, that is, adsorption of certain
sialoglycoproteins from culture medium onto the
parasite surface, as binding of SNA and MAA to
parasite membranes and culture medium
demonstrated the presence of analogous
sialoglycans37. This was reconfirmed with the
decreased binding of SNA and MAA to parasites
when cultured in decreasing concentrations of FCS.
Our investigations therefore demonstrate that the
parasite is “borrowing” sialoglycans from the culture
medium through simple adsorption to possibly
compensate for the deficient sialic acid37. It may be
speculated that incorporation of serum
sialoglycoconjugates onto the parasite surface might
be related to the membrane architecture, and they
are accordingly adsorbed under different stimuli or
stress conditions57. However, what remains to be
investigated is whether these adsorbed components
of FCS are transferred wholly or partially following
fragmentation by cellular enzymes or are degraded
otherwise.
Humoral responses of glycoconjugates of
L. donovani
Carbohydrate epitopes in parasitic infections are
also known to produce profound humoral response
in the host. The overall importance of glycan-
specific antibodies in protection against infection
or in the pathological nature of the infection is still
not clear, and only a relatively modest amount of
information is available about specific structures
or expression of relevant glycan antigens. This
section of the review highlights some of attempts
made from our laboratory in discovering antibodies
directed against these sialoglycotopes which can
cause complement mediated death of the
Leishmania promastigote.
Antibodies directed against sialoglycans, their
importance and role
Antibodies directed against carbohydrate epitopes
are reported to be present in the human host in high
titres. VL patients contain elevated levels of IgM and
IgG antibodies directed against 9-Oacetylated
sialoglycoconjugates (9-O-AcSG)61. These affinity
purified antibodies bound to 9-OAcSGs epitopes of
L. donovani promastigotes as detected through
Immunoflurescence microscopy. Remarkably,
immunofluorescence microscopic analysis revealed
a strong binding of this purified IgM with the cytosol
of L. donovani promastigotes. This binding appears
to be specific, because Achatinin-H, a snail lectin
with binding specificity toward 9-O-AcSA
a2,6GalNAc, also bound to promastigote cytosolic
glycotopes, and the binding of anti-O-AcSGIgM is
decreased after preincubation with Achatinin-H61
(Fig. 4). Because these purified anti-O-AcSG
antibodies showed significant binding to L. donovani
promastigotes, the biological relevance of these
disease-specific antibodies was next investigated. As
it is known that enhanced levels of O-AcSA
glycotopes can be correlated with an increased
sensitivity towards complement lysis. Therefore, the
biological relevance of these antibodies, with regard
to activation of the classical complement pathway
(CP), was investigated62.
The disease process of leishmaniasis is initiated
by promastigote inoculation into the host
macrophage62, whereby the host defense responds by
activating its complement system, culminating in
cleavage of the third complement component (C3)
and followed, ultimately, by the lytic pathway63-65.
This promastigote-C3 opsonization is mediated
mainly by 3 pathways—namely, the classical
pathway (CP), the alternate pathway (AP), and the
lectin-mediated pathway, leading to the formation
of a cytolytic membrane attack complex (C5b-9). The
involvement of anti-leishmanial IgM, a complement
activator minimally present in normal human serum
(NHS), causes parasite agglutination, CP activation,
and parasite killing66,67, Additionally, parasite-specific
IgG induces lysis of Leishmania and Trypanosoma
organisms67. Anti-O-AcSGs, even under normal
physiological conditions, could trigger CP mediated
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Fig. 4. Fluorescence microscopic analysis of anti-OAcSG IgM binding to Leishmania donovani promastigote. (Panel 1) Represents
binding of anti-O-AcSG IgM with L. donovani. A, Red fluorescence represents DNA binding. B, Green fluorescence represents anti-
O-AcSG binding. C, The merged image represents the localization of anti-O-AcSG binding in promastigotes. D, Represents the
differential interference contrast (DIC) image of the cells in view. (Panel 2) Control set for anti-OAcSG binding. Cells were preincubated
with Achatinin-H, whose lectinogenic glycotope has been previously defined as 9-O-AcSA, linked to subterminal GalNAc through
an α2-6 linkage, followed by addition of FITC-labeled anti-O-AcSG. The (E) red and (F) green fluorescence represents DNA and
anti-O-AcSA binding, respectively. G, The merged image represents the localization of anti-O-AcSA binding in promastigotes. (H)
represents the DIC image. (Panel 3) Represents binding of Achatinin-H with L. donovani. I, Red and (J) green fluorescence represents
DNA and Achatinin-H binding. K, The merged image represents the localization of binding of Achatinin-H in promastigotes. L,
Represents the DIC image. (Panel 4) The control set for Achatinin-H binding. M, Red and (N) green fluorescence represents DNA
binding and Achatinin-H binding. O, The merged image represents the localization of Achatinin-H binding in promastigotes. P,
represents the DIC image.
[Reproduced from (Ref. 61) with permission from Elsevier].
C3 (CP-C3) deposition on promastigotes, causing
their lysis, whereas other complement pathways were
demonstrated to play a negligible role (Fig. 5).
Anti-O-AcSGs from both healthy donors and
patients with VL elicited C3 deposition as early as
3 min, which triggered parasite lysis,  as
demonstrated by use of 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) assay
and corroborated by the high rate of uptake of PI62
(Fig. 6). Analysis of complement activation by
mannan-binding lectin and C-reactive protein
demonstrated their negligible contribution during
the 3-min time frame. Anti-O-AcSGs were thus
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Fig. 5. Classical complement pathway activation induced by anti–O-acetylated sialoglycoconjugate (AcSG)normal human serum
(NHS) vs. that induced by total antibodyNHS. The parasites were incubated in presence of Ads-NHS (25%) as a source of complement
and several complement activators. The amount of C3-deposition was measured by using 125I-anti-C3mAb. (A) A fixed concentration
(6 µg/ml) of different antibodies namely, Anti-O-AcSGIgMNHS (l), anti-O-AcSGIgGNHS (s), total IgMNHS (o) and total IgGNHS (∆)
was selected to study C3-deposition as induced by them individually at different time periods. (B) Comparison of C3-deposition
within 3 minutes as triggered by Anti-O-AcSGIgM (s, ∆) and anti-O-AcSGIgG (l, o) purified from sera of VL patients (s, l) and
NHS (∆, o) in different concentrations. (C) Comparison of C3-deposition within 3 minutes as triggered by 6 µg/ml of anti-O-
AcSGIgMVL ( ) and anti-O-AcSGIgGVL ( ) in four strains MHOM/IN/83/AG83 (1), MHOM/IN/90/GE1 (2), NS1(3) and NS2 (4)
isolated from VL patients.
[Reproduced from (Ref. 62) with permission of the publishers, the University of Chicago Press].
identified as an important source of CP activation
under normal physiological conditions, suggesting
that they play a role in conferring host protection
against parasite infection.
Previous reports have demonstrated that total IgM
antibodies present naturally in NHS are a source of
CP activation65. However, we have reported that anti-
O-AcSGNHS is 3-fold more potent than are total
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antibodies in NHS, demonstrating, for the first time,
that natural anti-O-AcSG is one of the major triggers
of CP activation and promastigote opsonization62.
Interestingly, in elicitation of C3 deposition on
promastigotes, purified disease-specific anti-O-AcSG
IgMVL and anti-O-AcSG IgGVL antibodies (6 µg/ml) were
5-fold more potent than anti-O-AcSG IgMNHS and anti-
O-AcSG IgGNHS antibodies (Fig. 6B). The enhanced
presence of 9-O-AcSG containing the 9-O-AcSAα2-
6GalNAc glycotope, on the parasite surface, has been
reported elsewhere37,38,68 and has been corroborated here
by the high rate of binding of anti-O-AcSG antibodies to
promastigotes. Therefore, the enhanced presence of
9-O-AcSGs on parasites corroborates their increased
susceptibility to complement lysis. Previous reports have
shown that, irrespective of their linkage specificity,
9-O-AcSGs present on the surface of murine erythrocytes
and murine erythroleukaemia cells contribute
significantly to their susceptibility to lysis by activation
of the AP69. Further investigations from our group have
shown that, in mammalian erythrocytes, the complement
lysis induced via the AP correlates more significantly
with linkage-specific 9-O-AcSAα2-6GalNAc70. This
correlation has been extended to erythrocytes from
patients with VL70.
Fig. 6. Induction of promastigote lysis due to C3 deposition induced by anti–O-acetylated sialoglycoconjugate (AcSG). (A) A
representative profile of cell death (%) as detected by MTT assay using 6 µg/ml of purified anti-O-AcSGIgMNHS (1) and anti-O-
AcSGIgGNHS (3) vs. total antibodiesNHS IgM (2) and IgG (4) in the presence of Ads-NHS (25%) within three minutes at 37oC. The
cells were washed and incubated for another 3 hours at 370C with MTT (100 µg/50 µl) and processed. (B) Comparison of cell death
in MHOM/IN/83/AG83 (1), MHOM/IN/90/GE1 (2), NS1(3) and NS2 (4) isolated from VL patients using fixed concentration of
6 µg/ml of different antibodies anti-O-AcSGIgMVL (  ) and anti-O-AcSGIgGVL (  ). (C-G) Promastigote lysis was also analyzed
by uptake of PI through Flow cytometric analysis as triggered by Ads-NHS (25%) along with 6 µg/ml of purified anti-O-AcSGIgMVL
(E), anti-O-AcSGIgMNHS (F) and total IgMNHS (G) as compared to absence of complement activators (C) and maximum PI uptake
(97%) after methanol : acetone treatment (D).
[Reproduced from (Ref. 62) with permission of the publishers, the University of Chicago Press].
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Sialic acids are critical determinants of parasite
protection against attack by the host complement
system71. The removal of sialic acid by treatment
with neuraminidase is known to increase MBL
binding, with a subsequent increase in MBL
mediated complement-dependant cell cytolysis, in
Neisseria meningiditis72. Sialylation is also known
to protect N. gonorrhoeae from MBL-activated
complement killing73 and confer protection to both
epimastigote and trypomastigote forms by hindering
the binding of lytic anti-galactose antibodies74.
Thus, it may be envisaged that the host induces
enhanced 9-O-acetylation on the parasite, thus
generating anti–9-O-AcSG titres that, in turn,
induce parasite lysis via CP activation. The role that
9-O-AcSG glycotopes on parasites play in
mediating complement activation was further
corroborated by O-acetylesterase-treated parasites,
which resulted in the removal of O-acetyl moiety
from sialic acid. These treated cells, when incubated
with anti-O-AcSG IgM and anti-O-AcSG IgG,
caused a significant reduction of C3 deposition.
Quantitation of the number of C3-bound molecules
per cell revealed that, in triggering the activation
of C3 deposition, anti-O-AcSG IgMVL was 2.5-fold
more potent than was anti-O-AcSG IgGVL62.
Interestingly, although total antibodies in NHS are
capable of inducing cell lysis, as confirmed by use
of MTT assay, however, they were 3-fold less potent
than anti-O-AcSGNHS, establishing the critical role
of these glycotope-specific antibodies. Further, anti-
O-AcSG–induced death, compared with that
induced by total antibodies in NHS, revealed a much
higher population of necrotic cells, as confirmed
by the massive uptake of PI. The importance of
9-O-AcSGs was further demonstrated when
promastigotes grown in serum-free medium were
found to be incapable of undergoing anti-O-AcSG-
mediated complement lysis; however, they became
susceptible to lysis when they were transferred to
medium supplemented with FCS, the source of this
interesting 9-O-AcSG62. The susceptibility to lysis,
even in medium supplemented with low FCS (5%),
confirmed that these glycotopes play important in
vivo roles in complement activation. In contrast to
CP, within the 3 min time frame, AP, CRP and MBL
have a negligible effect, and no cell death could be
detected during this time, as confirmed by use of
MTT assay62. A comparative analysis distinctly
revealed that the C3 deposition (mean ± SEM)
triggered by anti-O-AcSGVL (94% ± 5% by IgM
and 72% ± 10% by IgG) was maximal, compared
with that triggered by CRP (22% ± 9%), MBL (24%
± 5%), or AP (27% ±1.4%) (Fig. 7)65.
The above study demonstrated, for the first time,
the biological role that these OAcSG-specific
antibodies play in host protection. Thus, a vivid
analysis of the differential recognition of antigenic
glycoconjugates and antibodies is required for
comprehension of the immune response in VL.
Perspective
The Identification of novel molecular
determinants on L. donovani monitoring their mode
of acquisition and their subsequent characterization
will provide insight into the disease biology of
visceral leishmaniasis. Proteomics of these newly
identified molecules will lead to the development of
future vaccine candidate.
The influence of these molecules in triggering host
responses via the production of high titres of anti-O-
AcSA antibodies have also been reported61,62.
Therefore, identification of these antibodies and
probing for their detailed mechanism of their
interaction may help us in identifying novel anti-
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Fig. 7.  A comparative analysis of C3-deposition on
promastigotes by all the complement pathways as induced by
the different complement activators namely, CRP ( ) 50 µg/
ml, MBL ( ) 20 µg/ml, AP (   ), anti-O-AcSGVL IgM (   ) 6 µg/
ml or IgG ( ) 6 µg/ml within 3 min.
[Reproduced from (Ref. 62) with permission of the publishers,
the University of Chicago Press].
leishmanial molecules which may subsequently have
therapeutic application. A detailed understanding of
sialoglycans on L. donovani and their subsequent
interaction with the host will help to foster innovative
new strategies for diminishing the mortality and
morbidity caused by this pathogen.
The current problem in Indian leishmaniasis is the
increasing unresponsiveness to first-line treatment
with pentavalent antimonial drugs, namely sodium
antimony gluconate37. In view of the alarming
increase in antimonial unresponsiveness, it would be
interesting to study whether surface sialoglycans of
antimonial resistant parasites are differentially
adsorbed. They would then potentially serve as
molecular targets helpful in distinguishing drug-
responsive from drug unresponsive patients and
allowing development of new drug strategies. In the
future, it will be important to find whether these
sialylated determinants, especially the 9-O-acetylated
derivative, are present in other Leishmania strains,
whether their expression is stage-specific, and what
is the machinery that regulates sialylation and
O-acetylation of the Leishmania parasites. The
potential payback is a greater understanding of the
endogenous roles of sialoglycans that may be relevant
with regard to the host-parasite relationship.
The metabolism of O-AcSA is under the control
of two groups of enzymes, O-acetyltransferases and
9-O-acetylesterases75. O-acetyltransferases are
difficult to purify, and attempts to clone their genes
have failed in isolating the true 9-O-acetyltransferase
cDNA, accounting for the limited information
regarding expression of O-AcSA76. In this context it
is worthwhile to consider whether such a system
exists in L. donovani amastigotes; such studies are
underway. Parasitologic research is limited by the
lack of availability of genomic data on protozoa and
therefore the search for genes possibly involved in
the biosynthesis, activation or transfer of sialic acids
in protozoa has to be continued in the future.
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